Sign in
Home
Biotech Insights
Biotech News
CEO Interviews
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Privacy Policy
Password recovery
Recover your password
your email
Search
Sign in / Join
About Us
Privacy Policy
Disclaimer
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Home
Biotech Insights
Biotech News
CEO Interviews
CEO Interviews
BiotechStocktrader Interview with Nader Pourhassan, CEO of Cytodyn, Inc.
CEO Interviews
BiotechStocktrader Interview with Dr. Carl Schwartz, CEO of Precision Therapeutics, (AIPT).
CEO Interviews
BriaCell Therapeutics (BCTXF) Presents Positive Efficacy Data with Lead Cancer Drug Candidate
CEO Interviews
Hemispherx Biopharma (HEB) Showing Strong Progress in Clinical Trials
CEO Interviews
Innovus Pharmaceuticals Continues Strong Revenue Growth & New Product Rollouts
BioTechStockTrader
About Biotech Stocktrader
Alernative Pharma
Biotech Insights
Biotech News
CEO Interviews
COVID-19
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Cardiol Therapeutics Submits Application for Uplisting to the Nasdaq and Raises Proceeds of Over $10 Million from Exercise of...
BetterLife Pharma Inc.
-
March 2, 2021
0
Big Pharma Dives Into CBD: Who Could Be Next?
BetterLife Pharma Inc.
-
February 22, 2021
0
Cardiol Therapeutics Announces Completion of Phase I Clinical Study of CardiolRx™
BetterLife Pharma Inc.
-
December 22, 2020
0
Biotech News
Home
Biotech News
Page 2
Biotech News
BetterLife Announces Closing of Private Placement
BetterLife Pharma Inc.
-
August 19, 2020
0
Biotech News
Avivagen Announces Publication of Scientific Paper in British Journal of Nutrition
Avivagen Inc.
-
August 18, 2020
0
Biotech News
Generex Announces Signed Agreement with Bintai Kinden to Advance the Clinical...
Generex Biotechnology Corporation
-
August 18, 2020
0
Biotech News
Enzon Pharmaceuticals, Inc. Adopts Tax Benefits Preservation Plan to Protect its...
Enzon Pharmaceuticals, Inc.
-
August 17, 2020
0
1
2
3
...
22
Page 2 of 22
- Advertisement -
APPLE
New Capricor Data Reports 100 Percent Survival in Critical COVID-19 Patients...
Enzon Pharmaceuticals, Inc.
-
May 8, 2020
0
Biotech News
U.S. FDA Approves Company’s Expanded Access Protocol to Treat Additional Patients LOS ANGELES, April 29, 2020 (GLOBE NEWSWIRE) -- Capricor Therapeutics (“Capricor”) (NASDAQ: CAPR) a...
RECENT POSTS
Cardiol Therapeutics Submits Application for Uplisting to the Nasdaq and Raises Proceeds of Over...
Enzon Pharmaceuticals, Inc.
-
March 2, 2021
Big Pharma Dives Into CBD: Who Could Be Next?
Enzon Pharmaceuticals, Inc.
-
February 22, 2021
Clinical Trials Focus on COVID-19 and Acute Myocarditis
Enzon Pharmaceuticals, Inc.
-
January 19, 2021
Cardiol Therapeutics Announces Completion of Phase I Clinical Study of CardiolRx™
Enzon Pharmaceuticals, Inc.
-
December 22, 2020
